← Insider buys

IART

Integra LifeSciences Holdings Corporation · Healthcare

Insiders bought $102K of Integra LifeSciences Holdings Corporation in the last 12 months

1 insider bought on 1 day.

$102KBought, 12 mo
$0Sold, 12 mo
$1.0BMarket cap

IART over the last year

Insider buy filed (1 day)

Largest buyers, last 12 months

IART after insider buys

3 months after each buy, from the first price a copier could get.

−8.9%Average
−14.4 ptsVs S&P 500
2 of 5Higher

5 buys since 2017 with 3 months of prices.

Congress

Members reported 5 trades in IART since 2023.

Every filing

119 insider filings since 2016, newest first

IARTBuy

Jeffrey A Graves · Director

$102K+28.0%Nov 6
IARTSell

Jeffrey Mosebrook · SVP, Fin, Princ Acct Officer

$26K−3.0%Aug 20
IARTBuy

Stuart Essig · Exec. COB

$1.5M+3.0%May 24
IARTBuy

Barbara B Hill · Director

$996K+36.0%May 22
IARTSell

Robert T. Davis Jr. · EVP, Pres, TT

$305K−14.0%Mar 8
IARTSell

Jeffrey Mosebrook · SVP, Fin, PAO

$52K−5.0%Aug 10
IARTBuy

Eric Schwartz · EVP, GC, Sec

$100K+6.0%Jun 5
IARTBuy

Witte Jan De · President and CEO

$300K+156.0%Jun 2
IARTSell

Michael J. Mcbreen · EVP, Pres, CSS

$100K−6.0%Mar 8
IARTSell

Robert T. Davis Jr. · EVP, Pres, TT

$86K−3.0%Mar 3
IARTSell

Lisa Evoli · EVP and CHRO

$215K−17.0%Feb 28
IARTSell

Lisa Evoli · EVP and CHRO

$65K−6.0%Aug 11
IARTSell

Raymond G. Murphy · Director

$446K−10.0%Aug 8
IARTSell

Lisa Evoli · EVP and CHRO

$50K−4.0%Jun 16
IARTSell

Glenn Coleman · EVP and COO

$414K−13.0%Apr 6
IARTSell

Tru St Partnership, L.P. · 10% owner

$19.5M−3.0%Mar 25
IARTSell

Tru St Partnership, L.P. · 10% owner

$5.1M−1.0%Nov 19
IARTSell

Jeffrey Mosebrook · SVP, Fin, Princ Acct Officer

$50K−10.0%Nov 12
IARTSell

Michael J. Mcbreen · EVP, Pres, CSS

$247K−26.0%Nov 8
IARTSell

Glenn Coleman · EVP and COO

$316K−13.0%Nov 3
IARTSell

Tru St Partnership, L.P. · 10% owner

$14.0M−2.0%Oct 27
IARTSell

Peter J Arduini · President and CEO

$9.0M−35.0%Sep 7
IARTSell

Michael J. Mcbreen · EVP, Pres, CSS

$285K−23.0%Aug 10
IARTSell

Raymond G. Murphy · Director

$84K−2.0%Jun 7
IARTSell

Lisa Evoli · EVP and CHRO

$400K−41.0%May 11
IARTSell

Glenn Coleman · EVP and COO

$1.8M−44.0%Apr 19
IARTSell

Glenn Coleman · EVP and COO

$282K−11.0%Apr 15
IARTSell

Lisa Evoli · EVP and CHRO

$441K−45.0%Apr 15
IARTSell

Glenn Coleman · EVP and COO

$875K−26.0%Apr 12
IARTSell

Glenn Coleman · EVP and COO

$1.1M−30.0%Mar 30
IARTSell

Tru St Partnership, L.P. · 10% owner

$54.7M−8.0%Mar 22
IARTSell

Stuart Essig · Director

$14.6M−11.0%Mar 22
IARTSell

Jeffrey Mosebrook · SVP, Fin, Princ Acct Officer

$73K−16.0%Mar 3
IARTSell

Michael J. Mcbreen · EVP, Pres, CSS

$152K−12.0%Mar 3
IARTSell

Eric Schwartz · EVP, GC, Sec

$291K−15.0%Mar 3
IARTSell

Eric Schwartz · EVP, GC, Sec

$159K−8.0%Mar 1
IARTSell

Robert T. Davis Jr. · EVP, Pres, TT

$1.7M−56.0%Feb 26
IARTSell

Peter J Arduini · President and CEO

$1.5M−10.0%Feb 3
IARTSell

Tru St Partnership, L.P. · 10% owner

$12.2M−2.0%Dec 21
IARTSell

Peter J Arduini · President and CEO

$2.8M−17.0%Dec 21
IARTSell

Glenn Coleman · EVP and COO

$146K−7.0%Nov 17
IARTSell

Raymond G. Murphy · Director

$151K−4.0%Nov 13
IARTSell

Glenn Coleman · EVP and COO

$518K−20.0%Nov 12
IARTSell

Michael J. Mcbreen · EVP, Pres, CSS

$139K−11.0%Nov 10
IARTSell

Lisa Evoli · EVP and CHRO

$405K−51.0%Nov 10
IARTSell

Tru St Partnership, L.P. · 10% owner

$9.4M−2.0%Sep 21
IARTSell

Jeffrey Mosebrook · SVP, Fin, Princ Acct Officer

$42K−11.0%Aug 14
IARTSell

Glenn Coleman · EVP and COO

$261K−10.0%Aug 13
IARTSell

Richard E Caruso · 10% owner

$29.1M−5.0%Jun 22
IARTSell

Lisa Evoli · CHRO

$191K−35.0%Jun 8
About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.